GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
RPLs are enhanced glycoselective bioaffinity proteins that enable efficient detection, analysis and isolation of glycosylated biomolecules. RPLs can be used to enable simple and fast detection, analysis and isolation of intact glycosylated biomolecules. The RPLs can be used in many applications including Biopharmaceutical product development and production, in the Food Industry to extract valuable glycoproteins, and as a tool in Diagnostic and Research to identify glycan-based biomarkers, or to detect and analyze glycans in situ, for purposes of cell identification or classification of microorganisms or other infectious agents.
“Improved glycoselective tools for the Life Science Industries,,
These molecules present many advantages over existing analytical and purification methods. Their production is also readily scalable, enabling their use for all applications, from analytical to production scale.